IBMS Congress 2022: from cellular pathology to immunology

Summaries of lectures on the IBMS Science Congress scientific lecture programme are requested from individual speakers. In this first of two reviews, Pathology in Practice selects highlights from alphabetically cellular pathology to immunology.

The fourteenth biennial IBMS Congress scientific programme once again illustrated the diverse and evolving nature of specialties that comprise biomedical science and laboratory medicine. Reproduced below are selected summaries of presentations given on the cellular pathology, clinical chemistry, cytopathology, haematology and immunology programmes.

Recent advances in immunocytochemistry for melanoma diagnosis

Malignant melanoma (MM) remains the deadliest form of skin cancer. It is well known that MM can be treated with surgery alone and survival rates are high; however, after metastasis survival rates drop significantly. In histopathological interpretation morphological assessment of any melanocytic lesion is always key, but recent developments within the field of immunocytochemistry (ICC) have provided great support in aiding the distinction of the dysplastic verses malignant lesions. This does not just apply to the diagnosis, but also more recently in providing information regarding prognosis and determining patient therapeutics.

Log in or register FREE to read the rest

This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text. If you don't already have an account, please register with us completely free of charge.

Latest Issues

Med-Tech Innovation Expo

NEC, Birmingham
5-6 June, 2024


DoubleTree by Hilton Brighton Metropole
10-12 June, 2024

Infection Diagnostics Symposium 2024

IET Austin Court, Birmingham
26-27 June, 2024

SHOT Symposium 2024

Mercure Manchester Piccadilly Hotel
9 July, 2024